2013•Annals of OncologyOpen access

Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer

Brian Matthew Wolpin, Eileen Mary O'Reilly, Yoo-Joung Ko, Lawrence Scott Blaszkowsky, Mark U. Rarick, Caio Rocha‐Lima, Paul S. Ritch, Emily W. Chan, Jennifer L. Spratlin, Teresa Mercade Macarulla, Elaine McWhirter, Denis Pezet, Mikhail Lichinitser, Laslo Roman, Alan C. Hartford, Kendall Morrison, Lee R. Jackson, Martha Vincent, Leonard M. Reyno, Manuel M. Hidalgo

Open full text 35 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 35 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Gemcitabine, Medicine, Clinical endpoint, Pancreatic cancer, Internal medicine, Adenocarcinoma, Phases of clinical research, Oncology